Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): A randomised, double-blind, placebo-controlled trial

The Lancet

Volumn 377, Issue 9766, 2011, Pages 650-657

  Martinez, Fernando D ^a   Chinchilli, Vernon M ^b   Morgan, Wayne J ^a   Boehmer, Susan J ^b   Lemanske Jr , Robert F ^c   Mauger, David T ^b   Strunk, Robert C ^d   Szefler, Stanley J ^e   Zeiger, Robert S ^f   Bacharier, Leonard B ^d   Bade, Elizabeth ^g   Covar, Ronina A ^e   Friedman, Noah J ^f   Guilbert, Theresa W ^c   Heidarian Raissy, Hengameh ^h   Kelly, H William ^h   Malka Rais, Jonathan ^e   Mellon, Michael H ^f   Sorkness, Christine A ^c   Taussig, Lynn ⁱ  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; PLACEBO; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; BRONCHITIS; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UNITED STATES; VIRUS MENINGITIS;

EID: 79951812951     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62145-9     Document Type: Article

References (26)

1. National Asthma Education Prevention Program Coordinating Committee Expert Panel. Guidelines for the diagnosis and management of asthma, 2007. http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 17 Jan, 2011).
2. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2009. http://www.ginasthma.com/Guidelineitem.asp??l1= 2&l2=1&intId=1561 (accessed Jan 17, 2011).
3. Burgess SW, Sly PD, Morawska A, Devadason SG. Assessing adherence and factors associated with adherence in young children with asthma. Respirology 2008; 13: 559-63. (Pubitemid 351725284)
4. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007; 119: 64-72. (Pubitemid 46043379)
5. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054-63.
6. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171: 129-36. (Pubitemid 40105411)
7. Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006; 129: 246-56. (Pubitemid 43289841)
8. Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006; 130: 1733-43. (Pubitemid 46033427)
9. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356: 2040-52. (Pubitemid 46789894)
10. National Asthma Education Prevention Program Coordinating Committee. Expert Panel II. Guidelines for the diagnosis and management of asthma. In: National Institutes of Health; 1997.
11. McAlister FA, Straus SE, Sackett DL, Altman DG. Analysis and reporting of factorial trials: a systematic review. JAMA 2003; 289: 2545-53. (Pubitemid 37430156)
12. Lubsen J, Pocock SJ. Factorial trials in cardiology: pros and cons. Eur Heart J 1994; 15: 585-88. (Pubitemid 24186322)
13. Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009; 360: 2079-89.
14. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-02.
15. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma - The Dutch Asthma Study Group. Am J Respir Crit Care Med 1998; 158: 213-19. (Pubitemid 28337183)
16. Simons FE. A comparison of beclomethasone, meterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997; 337: 1659-65.
17. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-97.
18. Martinez FD. Managing childhood asthma: challenge of preventing exacerbations. Pediatrics 2009; 123 (suppl 3): S146-50.
19. Turpeinen M, Nikander K, Pelkonen AS, et al. Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study). Arch Dis Child 2008; 93: 654-59.
20. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009; 360: 339-53.
21. FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004; 59: 550-56. (Pubitemid 38901511)
22. Bacharier LB, Phillips BR, Zeiger RS, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008; 122: 1127-35.
23. Boushey HA, Sorkness CA, King TS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 1519-28.
24. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738-43. (Pubitemid 32881906)
25. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215-18. (Pubitemid 40380280)
26. Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pediatrics 2002; 109: e92.